Xiangjun Jiang

1.5k total citations · 1 hit paper
15 papers, 1.1k citations indexed

About

Xiangjun Jiang is a scholar working on Epidemiology, Oncology and Hepatology. According to data from OpenAlex, Xiangjun Jiang has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 5 papers in Oncology and 5 papers in Hepatology. Recurrent topics in Xiangjun Jiang's work include Liver Disease Diagnosis and Treatment (7 papers), Liver Disease and Transplantation (3 papers) and Hepatitis B Virus Studies (3 papers). Xiangjun Jiang is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Liver Disease and Transplantation (3 papers) and Hepatitis B Virus Studies (3 papers). Xiangjun Jiang collaborates with scholars based in China and United States. Xiangjun Jiang's co-authors include Zhonghua Lin, Shiying Xuan, Quanjiang Dong, Shu-Hui Zhan, Ying Sun, Qing Wang, Yongning Xin, Wenwen Jin, Lizhen Chen and Liping Zhao and has published in prestigious journals such as Hepatology, Proteins Structure Function and Bioinformatics and World Journal of Gastroenterology.

In The Last Decade

Xiangjun Jiang

15 papers receiving 1.1k citations

Hit Papers

Performance of the Aspartate Aminotransferase-to-Platelet... 2010 2026 2015 2020 2010 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangjun Jiang China 12 891 767 153 99 82 15 1.1k
Hidekatsu Kuroda Japan 18 597 0.7× 574 0.7× 142 0.9× 57 0.6× 48 0.6× 82 890
Lindsay Y. King United States 12 554 0.6× 520 0.7× 153 1.0× 60 0.6× 58 0.7× 41 817
Guangqin Xiao China 12 1.0k 1.2× 819 1.1× 205 1.3× 164 1.7× 162 2.0× 21 1.3k
J.F. Sánchez-Ávila Mexico 15 794 0.9× 802 1.0× 142 0.9× 47 0.5× 70 0.9× 50 1.0k
Yoshitaka Takuma Japan 16 680 0.8× 699 0.9× 285 1.9× 60 0.6× 107 1.3× 31 1.0k
Ki Tae Yoon South Korea 19 767 0.9× 744 1.0× 267 1.7× 157 1.6× 55 0.7× 77 1.2k
Satoshi Oeda Japan 13 445 0.5× 369 0.5× 186 1.2× 124 1.3× 89 1.1× 37 651
Masanori Atsukawa Japan 18 729 0.8× 714 0.9× 213 1.4× 31 0.3× 102 1.2× 85 1.0k
Koichi Takaguchi Japan 19 786 0.9× 941 1.2× 146 1.0× 88 0.9× 31 0.4× 58 1.1k
Antonio Ascione Italy 19 1.4k 1.6× 1.5k 1.9× 160 1.0× 55 0.6× 65 0.8× 53 1.7k

Countries citing papers authored by Xiangjun Jiang

Since Specialization
Citations

This map shows the geographic impact of Xiangjun Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangjun Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangjun Jiang more than expected).

Fields of papers citing papers by Xiangjun Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangjun Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangjun Jiang. The network helps show where Xiangjun Jiang may publish in the future.

Co-authorship network of co-authors of Xiangjun Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangjun Jiang. A scholar is included among the top collaborators of Xiangjun Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangjun Jiang. Xiangjun Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zhang, Ran, et al.. (2021). A Recombinant Human Adenovirus Type 5 (H101) Combined With Chemotherapy for Advanced Gastric Carcinoma: A Retrospective Cohort Study. Frontiers in Oncology. 11. 752504–752504. 16 indexed citations
2.
Zhang, Jian, et al.. (2021). A case of primary intestinal lymphangiectasia with non-Hodgkin lymphoma. BMC Gastroenterology. 21(1). 461–461. 1 indexed citations
3.
Tang, Jieting, Yongfeng Wang, Tao Han, et al.. (2020). Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial. BMC Gastroenterology. 20(1). 391–391. 6 indexed citations
4.
Chen, Lizhen, Shousheng Liu, Qun Liu, et al.. (2019). Combining I148M and E167K variants to improve risk prediction for nonalcoholic fatty liver disease in Qingdao Han population, China. Lipids in Health and Disease. 18(1). 45–45. 12 indexed citations
5.
Rao, Huiying, Guangming Li, Yongfeng Yang, et al.. (2019). Safety and efficacy of coblopasvir and sofosbuvir in patients with genotypes 1, 2, 3 and 6 HCV infections without or with compensated cirrhosis. Journal of Viral Hepatitis. 27(1). 45–51. 2 indexed citations
6.
Liu, Pei, et al.. (2019). Stat‐3 signaling promotes cell proliferation and metastasis of gastric cancer through PDCD4 downregulation. The Kaohsiung Journal of Medical Sciences. 36(4). 244–249. 12 indexed citations
7.
Cui, Lin, et al.. (2018). C1QTNF6 is overexpressed in gastric carcinoma and contributes to the proliferation and migration of gastric carcinoma cells. International Journal of Molecular Medicine. 43(1). 621–629. 23 indexed citations
8.
Chen, Lizhen, Shui-Xian Du, Zhonghua Lin, et al.. (2017). The additive effects of theTM6SF2 E167KandPNPLA3 I148Mpolymorphisms on lipid metabolism. Oncotarget. 8(43). 74209–74216. 15 indexed citations
9.
Zhao, Liping, Shu-Hui Zhan, Chang-Xin Geng, et al.. (2016). Clinicopathological and prognostic significance of programmed cell death ligand 1 (PD-L1) expression in patients with esophageal squamous cell carcinoma: a meta-analysis. Journal of Thoracic Disease. 8(11). 3197–3204. 35 indexed citations
10.
Chen, Lizhen, Zhonghua Lin, Man Jiang, et al.. (2015). Genetic Variants in the SAMM50 Gene Create Susceptibility to Nonalcoholic Fatty Liver Disease in a Chinese Han Population. Hepatitis Monthly. 15(10). e31076–e31076. 20 indexed citations
11.
Jin, Wenwen, Zhonghua Lin, Yongning Xin, et al.. (2012). Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterology. 12(1). 14–14. 114 indexed citations
12.
Jiang, Xiangjun. (2012). Endoscopic stenting and concurrent chemoradiotherapy for advanced esophageal cancer: A case-control study. World Journal of Gastroenterology. 18(12). 1404–1404. 12 indexed citations
13.
Xin, Yongning, et al.. (2012). Molecular dynamics simulation of PNPLA3 I148M polymorphism reveals reduced substrate access to the catalytic cavity. Proteins Structure Function and Bioinformatics. 81(3). 406–414. 13 indexed citations
14.
Lin, Zhonghua, Quanjiang Dong, Qing Wang, et al.. (2010). Performance of the Aspartate Aminotransferase-to-Platelet Ratio Index for the Staging of Hepatitis C-Related Fibrosis: An Updated Meta-Analysis §Δ. Hepatology. 53(3). 726–736. 796 indexed citations breakdown →
15.
Lin, Zhonghua, Yongning Xin, Quanjiang Dong, et al.. (2010). Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma: a meta-analysis. BMC Gastroenterology. 10(1). 145–145. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026